Our statistical approaches demonstrate that besides the GOT and GPT levels, disorders of lipid metabolism, and obesity, certain other factors, such as demographic characteristics, clinical parameters, and different comorbidities may be critical determinants of survival as well. This evidence concerns the gene GPT and obesity disorder.